Trial intelligence / Profile preview

Pentoxifylline-tocopherol and Hyperbaric Oxygen for Radiation-induced Fibrosis

NCT01822405Phase 2Unknown

Sponsor
Hospital Universitario de Canarias
Start
Jul 2010
Primary completion
Jul 2013
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of pentoxifylline, tocopherol in radiation-induced fibrosis (RIF), sponsored by Hospital Universitario de Canarias. Status: unknown.

02

Drugs

pentoxifyllinetocopherol
03

Conditions

radiation-induced fibrosis (RIF)

Beyond the preview

Go deeper on NCT01822405.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01822405.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call